Staff editor
"MIBIOC - The way of the microbiota in cancer" - IRCCS National Cancer Institute, Milan, 21-22th November 2019.
Imbalances of microbes, which are normally present on the skin, are one of the main subjects raised during the 24thCongress of Dermatology.
Rates of food allergy in children are spiking and it’s not certain why this increase in prevalence has occurred. The gut microbiome could play a role.
Find out how to be one of the 250+ microbiome leaders attending the definitive microbiome therapeutics meeting in Boston this June.
The relationship between bacteria and cancer is more and more investigated. We discuss it with Laurence Zitvogel, oncologist at the Institut Gustave Roussy.
Bacteria are critical in determining the outcome of surgical procedure. We talked about this with James Kinross from the Imperial College London.
The microbiome may be a source for biomarkers leading to therapeutic discoveries and diagnostics. We discuss it with Emily Hollister, Vice President of Diversigen.
Richard Ellis, Head of Business Development at Biose, explains how CDMO companies assist start-ups in bringing live biotherapeutic products to the market.
Researchers from the University of Trento have found that specific changes in gut microbiota composition are associated with colorectal cancer.
What characteristics will the probiotics of the future have? We asked Antonio Gasbarrini, director of CEMAD at the Policlinico Gemelli.
